Header

UZH-Logo

Maintenance Infos

Hybrid coronary revascularization: promising, but yet to take off


Panoulas, Vasileios F; Colombo, Antonio; Margonato, Alberto; Maisano, Francesco (2015). Hybrid coronary revascularization: promising, but yet to take off. Journal of the American College of Cardiology, 65(1):85-97.

Abstract

Hybrid coronary revascularization (HCR) combines arterial coronary artery bypass surgery (most commonly minimally invasive) and percutaneous coronary intervention in the treatment of a particular subset of multivessel coronary artery disease. It was first introduced in the mid-1990s, and aspired to bring together the "best of both worlds": the excellent patency rates and survival benefits associated with the durable left internal mammary artery graft to the left anterior descending artery alongside the good patency rates of drug-eluting stents, which outlive saphenous vein grafts to non-left anterior descending vessels. Although in theory this is a very attractive revascularization strategy, several years later, only one small randomized controlled trial comparing HCR with coronary artery bypass grafting has recently emerged in the medical literature, raising concerns regarding HCR's role and generalizability. In the current review, we discuss HCR's rationale, the current evidence behind it, its limitations and procedural challenges.

Abstract

Hybrid coronary revascularization (HCR) combines arterial coronary artery bypass surgery (most commonly minimally invasive) and percutaneous coronary intervention in the treatment of a particular subset of multivessel coronary artery disease. It was first introduced in the mid-1990s, and aspired to bring together the "best of both worlds": the excellent patency rates and survival benefits associated with the durable left internal mammary artery graft to the left anterior descending artery alongside the good patency rates of drug-eluting stents, which outlive saphenous vein grafts to non-left anterior descending vessels. Although in theory this is a very attractive revascularization strategy, several years later, only one small randomized controlled trial comparing HCR with coronary artery bypass grafting has recently emerged in the medical literature, raising concerns regarding HCR's role and generalizability. In the current review, we discuss HCR's rationale, the current evidence behind it, its limitations and procedural challenges.

Statistics

Citations

Dimensions.ai Metrics
22 citations in Web of Science®
21 citations in Scopus®
30 citations in Microsoft Academic
Google Scholar™

Altmetrics

Downloads

20 downloads since deposited on 02 Feb 2016
9 downloads since 12 months
Detailed statistics

Additional indexing

Item Type:Journal Article, refereed, original work
Communities & Collections:04 Faculty of Medicine > University Hospital Zurich > Clinic for Cardiovascular Surgery
Dewey Decimal Classification:610 Medicine & health
Language:German
Date:6 January 2015
Deposited On:02 Feb 2016 13:25
Last Modified:14 Feb 2018 10:49
Publisher:Elsevier
ISSN:0735-1097
OA Status:Hybrid
Publisher DOI:https://doi.org/10.1016/j.jacc.2014.04.093
PubMed ID:25572514

Download

Download PDF  'Hybrid coronary revascularization: promising, but yet to take off'.
Preview
Content: Published Version
Filetype: PDF (http://www.elsevier.com/open-access/userlicense/1.0/)
Size: 533kB
View at publisher